Skip to content
StockMarketAgent
Direct answer
HCA trades against a final fair-value range of $496.77-$798.49, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $497, high $798, with mid-point at $647.
Stock analysis

HCA HCA fair value $497–$798

HCA
By StockMarketAgent.AI team· supervised by
분석일: 2026-05-13다음 업데이트: 2026-08-13Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
주가
$426.37
▲ +220.89 (+51.81%)
공정 가치
$647
$497–$798
등급
적극 매수
confidence 88/100
상승 여력
+51.8%
upside to fair value
안전 마진
$550.17
MoS level · 15%
시가총액
$94.6B
P/E fwd 12.9
영어 원본으로 대체KO
번역하는 동안 영어 원본을 표시 중
이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

§1 개요

  • Composite fair value $647 with high case $798.
  • Implied upside of 51.8% to fair value.
  • Moat 9/10 · confidence 88/100 · Mature compounder.
  • Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$647
Margin of safety
+34.1%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$426.37Price
Low $496.77
Mid $647.26
High $798.49

HCA trades against a final fair-value range of $496.77-$798.49, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Local market density and scale
    Local market density and scale advantages driving industry-leading margins.
  • Demographic tailwinds with an aging
    Demographic tailwinds with an aging population ensuring consistent volume.
  • Bull thesis
    Market under-appreciates the durability of HCA's local market density and the resultant ROIC/WACC spread.

§2 베어 케이스

A prolonged period of elevated interest rates combined with flat commercial volumes and margin compression to 13% would severely stress HCA's free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics., threatening the heavily leveraged capital structure and ending the share repurchase algorithm.

이 논제가 무너지는 경로

Severe Reimbursement Cuts

· Medium

Government payers drastically compress Medicare/Medicaid rates to manage ballooning deficits, crushing margins.

FV impact
Downside anchoring near Expected Value of $421
Trigger
12 to 24 months

Structural Labor Shortage

· High

Persistent clinical staff shortages force a permanent reliance on expensive contract labor, eroding operating margins below 14%.

FV impact
Valuation anchors to Forward Earnings mid $420
Trigger
6 to 18 months

Debt Cost Spiral

· Low

Refinancing the massive $48.7B net debt load at significantly higher rates extinguishes the aggressive buyback program.

FV impact
Severe reduction in Owner Earnings fair value and DCF upside
Trigger
24 to 36 months
모니터링할 조기 경보 신호
지표현재트리거 임계값
Operating margin falling below 14.0% in consecutive quarters.MonitorDeterioration versus the report thesis
Year-over-year reduction in diluted shares outstanding falling below 3%.MonitorDeterioration versus the report thesis
Sustained acceleration in contract labor costs.MonitorDeterioration versus the report thesis
Negative shift in payer mix toward government and uninsured.MonitorDeterioration versus the report thesis
Deterioration of free cash flow conversion below $7B annually.MonitorDeterioration versus the report thesis

§3 재무 이력

손익계산서 — 최근 6기
항목T−0T−1T−2T−3T−4CAGR
기간2021-12-312022-12-312023-12-312024-12-312025-12-31Trend
매출$60.23B$64.97B$70.60B$75.60B+5.8%
매출총이익$23.18B$25.58B$28.68B$31.37B+7.9%
영업이익$9.05B$9.63B$10.55B$11.97B+7.2%
순이익$5.64B$5.24B$5.76B$6.78B+4.7%
EPS (희석)$19.15$18.97$22.00$28.33+10.3%
EBITDA$13.29B$12.72B$13.90B$15.60B+4.1%
R&D
판관비$26.78B$27.69B$29.49B$31.17B+3.9%

품질 점수

OCF / 순이익
1.86×
>1은 이익의 질이 높음을 의미
회계 품질 게이트
Fail
섹터 조정 게이트
ROIC
22.4%
투하자본수익률
섹션 3

Numbers analysis

현금 흐름

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

자본 배분

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

개인 구독자 — §4부터11개 섹션 더

전체 분석 읽기 — 11개 섹션 더.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

모든 커버 종목에 대한 전체 보고서
24개월 등급 아카이브
관심 목록 브리핑 + 등급 변경 알림
모든 언어로 PDF + DOCX 내보내기
무료 체험 시작
언제든지 취소 가능.
FAQ

HCA — frequently asked questions

  1. Based on our latest analysis, HCA looks meaningfully undervalued. The current price is $426 versus a composite fair-value midpoint of $647 (range $497–$798), which implies roughly 51.8% upside to the midpoint.
Related coverage

Names readers of HCA also follow

Same archetype: mature-compounder